Related Experiment Videos
UK experience in neonatal extracorporeal membrane oxygenation
G A Pearson1, D J Field, R K Firmin
1Department of Surgery, Groby Road Hospital, Leicester.
Archives of Disease in Childhood
|July 1, 1992
Summary
Extracorporeal membrane oxygenation (ECMO) offers vital life support for neonates with respiratory failure. Initial UK experience shows an 80% survival rate in critically ill infants, even those exceeding standard treatment criteria.
Area of Science:
- Neonatal Medicine
- Cardiopulmonary Support
- Pediatric Critical Care
Background:
- Extracorporeal membrane oxygenation (ECMO) is a critical life support technology.
- It is particularly effective for neonatal respiratory failure.
- Established criteria guide ECMO treatment decisions.
Purpose of the Study:
- To report the initial United Kingdom experience with ECMO in neonates.
- To evaluate the efficacy of ECMO in cases exceeding standard treatment criteria.
- To assess survival rates in a cohort of critically ill neonates.
Main Methods:
- Retrospective analysis of 15 neonates treated with ECMO.
- Patients were selected based on severe respiratory failure, exceeding standard ECMO criteria.
- Data collected included gestational age, birth weight, age at referral, and duration of ECMO support.
Main Results:
- A high survival rate of 80% was achieved in the study cohort.
- Neonates treated had gestations of 36-41 weeks and birth weights of 2690-3990 g.
- Referral ages ranged from 11 to 240 hours, with bypass durations from 30 to 240 hours.
Conclusions:
- ECMO can be highly successful in neonatal respiratory failure, even in complex cases.
- The UK's initial experience demonstrates a favorable survival rate.
- Careful patient selection and timely intervention are crucial for positive outcomes.